Literature DB >> 26204992

Modeling spread of KPC-producing bacteria in long-term acute care hospitals in the Chicago region, USA.

Manon R Haverkate1, Martin C J Bootsma1, Shayna Weiner2, Donald Blom2, Michael Y Lin2, Karen Lolans3, Nicholas M Moore4, Rosie D Lyles5, Robert A Weinstein2, Marc J M Bonten1, Mary K Hayden2.   

Abstract

OBJECTIVE: Prevalence of bla KPC-encoding Enterobacteriaceae (KPC) in Chicago long-term acute care hospitals (LTACHs) rose rapidly after the first recognition in 2007. We studied the epidemiology and transmission capacity of KPC in LTACHs and the effect of patient cohorting.
METHODS: Data were available from 4 Chicago LTACHs from June 2012 to June 2013 during a period of bundled interventions. These consisted of screening for KPC rectal carriage, daily chlorhexidine bathing, medical staff education, and 3 cohort strategies: a pure cohort (all KPC-positive patients on 1 floor), single rooms for KPC-positive patients, and a mixed cohort (all KPC-positive patients on 1 floor, supplemented with KPC-negative patients). A data-augmented Markov chain Monte Carlo (MCMC) method was used to model the transmission process.
RESULTS: Average prevalence of KPC colonization was 29.3%. On admission, 18% of patients were colonized; the sensitivity of the screening process was 81%. The per admission reproduction number was 0.40. The number of acquisitions per 1,000 patient days was lowest in LTACHs with a pure cohort ward or single rooms for colonized patients compared with mixed-cohort wards, but 95% credible intervals overlapped.
CONCLUSIONS: Prevalence of KPC in LTACHs is high, primarily due to high admission prevalence and the resultant impact of high colonization pressure on cross transmission. In this setting, with an intervention in place, patient-to-patient transmission is insufficient to maintain endemicity. Inclusion of a pure cohort or single rooms for KPC-positive patients in an intervention bundle seemed to limit transmission compared to use of a mixed cohort.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26204992     DOI: 10.1017/ice.2015.163

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  11 in total

Review 1.  Chlorhexidine: Patient Bathing and Infection Prevention.

Authors:  Salma Abbas; Sangeeta Sastry
Journal:  Curr Infect Dis Rep       Date:  2016-08       Impact factor: 3.725

2.  Extended models for nosocomial infection: parameter estimation and model selection.

Authors:  Alun Thomas; Karim Khader; Andrew Redd; Molly Leecaster; Yue Zhang; Makoto Jones; Tom Greene; Matthew Samore
Journal:  Math Med Biol       Date:  2018-03-16       Impact factor: 1.854

3.  Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study.

Authors:  David van Duin; Cesar A Arias; Lauren Komarow; Liang Chen; Blake M Hanson; Gregory Weston; Eric Cober; Omai B Garner; Jesse T Jacob; Michael J Satlin; Bettina C Fries; Julia Garcia-Diaz; Yohei Doi; Sorabh Dhar; Keith S Kaye; Michelle Earley; Andrea M Hujer; Kristine M Hujer; T Nicholas Domitrovic; William C Shropshire; An Dinh; Claudia Manca; Courtney L Luterbach; Minggui Wang; David L Paterson; Ritu Banerjee; Robin Patel; Scott Evans; Carol Hill; Rebekka Arias; Henry F Chambers; Vance G Fowler; Barry N Kreiswirth; Robert A Bonomo
Journal:  Lancet Infect Dis       Date:  2020-03-06       Impact factor: 25.071

4.  Effectiveness of Contact Precautions to Prevent Transmission of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci in Intensive Care Units.

Authors:  Karim Khader; Alun Thomas; W Charles Huskins; Vanessa Stevens; Lindsay T Keegan; Lindsay Visnovsky; Matthew H Samore
Journal:  Clin Infect Dis       Date:  2021-01-29       Impact factor: 9.079

5.  Transmission Dynamics of Clostridioides difficile in 2 High-Acuity Hospital Units.

Authors:  Karim Khader; L Silvia Munoz-Price; Ryan Hanson; Vanessa Stevens; Lindsay T Keegan; Alun Thomas; Liliana E Pezzin; Ann Nattinger; Siddhartha Singh; Matthew H Samore
Journal:  Clin Infect Dis       Date:  2021-01-29       Impact factor: 9.079

6.  Duration of Colonization With Klebsiella pneumoniae Carbapenemase-Producing Bacteria at Long-Term Acute Care Hospitals in Chicago, Illinois.

Authors:  Manon R Haverkate; Shayna Weiner; Karen Lolans; Nicholas M Moore; Robert A Weinstein; Marc J M Bonten; Mary K Hayden; Martin C J Bootsma
Journal:  Open Forum Infect Dis       Date:  2016-08-30       Impact factor: 3.835

7.  A Dynamic Transmission Model to Evaluate the Effectiveness of Infection Control Strategies.

Authors:  Karim Khader; Alun Thomas; W Charles Huskins; Molly Leecaster; Yue Zhang; Tom Greene; Andrew Redd; Matthew H Samore
Journal:  Open Forum Infect Dis       Date:  2017-02-10       Impact factor: 3.835

8.  Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria?

Authors:  Martin Exner; Sanjay Bhattacharya; Bärbel Christiansen; Jürgen Gebel; Peter Goroncy-Bermes; Philippe Hartemann; Peter Heeg; Carola Ilschner; Axel Kramer; Elaine Larson; Wolfgang Merkens; Martin Mielke; Peter Oltmanns; Birgit Ross; Manfred Rotter; Ricarda Maria Schmithausen; Hans-Günther Sonntag; Matthias Trautmann
Journal:  GMS Hyg Infect Control       Date:  2017-04-10

9.  Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant Enterococcus faecium outbreaks: a 6-year prospective study in a French multihospital institution, January 2010 to December 2015.

Authors:  Sandra Fournier; Laure Desenfant; Catherine Monteil; Michèle Nion-Huang; Christian Richard; Vincent Jarlier
Journal:  Euro Surveill       Date:  2018-02

10.  Dissemination mechanisms of NDM genes in hospitalized patients.

Authors:  Yuting Zhai; Shinyoung Lee; Lin Teng; Zhengxin Ma; Nicole B Hilliard; Robert J May; Scott A Brown; Fahong Yu; Kathryn E Desear; Kartik Cherabuddi; Kenneth H Rand; J Glenn Morris; Nicole M Iovine; KwangCheol C Jeong
Journal:  JAC Antimicrob Resist       Date:  2021-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.